McKeating JA - Search Results

1

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies.

Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, Harris HJ, Schwarz A, Desombere I, Roels GL, Balfe P, McKeating JA. Timpe JM, et al. Among authors: mckeating ja. Hepatology. 2008 Jan;47(1):17-24. doi: 10.1002/hep.21959. Hepatology. 2008. PMID: 17941058

2

Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120.

McKeating JA, Cordell J, Dean CJ, Balfe P. McKeating JA, et al. Virology. 1992 Dec;191(2):732-42. doi: 10.1016/0042-6822(92)90249-o. Virology. 1992. PMID: 1280382

3

Recombinant CD4-selected human immunodeficiency virus type 1 variants with reduced gp120 affinity for CD4 and increased cell fusion capacity.

McKeating J, Balfe P, Clapham P, Weiss RA. McKeating J, et al. J Virol. 1991 Sep;65(9):4777-85. doi: 10.1128/JVI.65.9.4777-4785.1991. J Virol. 1991. PMID: 1870202 Free PMC article.

4

Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.

McKeating JA, Shotton C, Cordell J, Graham S, Balfe P, Sullivan N, Charles M, Page M, Bolmstedt A, Olofsson S, et al. McKeating JA, et al. J Virol. 1993 Aug;67(8):4932-44. doi: 10.1128/JVI.67.8.4932-4944.1993. J Virol. 1993. PMID: 7687306 Free PMC article.

5

Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino acid change in gp120.

McKeating JA, Bennett J, Zolla-Pazner S, Schutten M, Ashelford S, Brown AL, Balfe P. McKeating JA, et al. J Virol. 1993 Sep;67(9):5216-25. doi: 10.1128/JVI.67.9.5216-5225.1993. J Virol. 1993. PMID: 7688820 Free PMC article.

6

Functional characterization of the V1V2 region of human immunodeficiency virus type 1.

Palmer C, Balfe P, Fox D, May JC, Frederiksson R, Fenyö EM, McKeating JA. Palmer C, et al. Among authors: mckeating ja. Virology. 1996 Jun 15;220(2):436-49. doi: 10.1006/viro.1996.0331. Virology. 1996. PMID: 8661394 Free article.

7

Chimeric viruses expressing primary envelope glycoproteins of human immunodeficiency virus type I show increased sensitivity to neutralization by human sera.

McKeating JA, Zhang YJ, Arnold C, Frederiksson R, Fenyö EM, Balfe P. McKeating JA, et al. Virology. 1996 Jun 15;220(2):450-60. doi: 10.1006/viro.1996.0332. Virology. 1996. PMID: 8661395 Free article.

8

Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.

Fox DG, Balfe P, Palmer CP, May JC, Arnold C, McKeating JA. Fox DG, et al. Among authors: mckeating ja. J Virol. 1997 Jan;71(1):759-65. doi: 10.1128/JVI.71.1.759-765.1997. J Virol. 1997. PMID: 8985413 Free PMC article.

9

Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants.

Lewis J, Balfe P, Arnold C, Kaye S, Tedder RS, McKeating JA. Lewis J, et al. Among authors: mckeating ja. J Virol. 1998 Nov;72(11):8943-51. doi: 10.1128/JVI.72.11.8943-8951.1998. J Virol. 1998. PMID: 9765439 Free PMC article.

10

The role of the viral glycoprotein in HIV-1 persistence.

McKeating JA, Balfe P. McKeating JA, et al. Immunol Lett. 1999 Jan;65(1-2):63-70. doi: 10.1016/s0165-2478(98)00126-6. Immunol Lett. 1999. PMID: 10065629 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters